The Evolving Biomarker Landscape for Treatment Selection in Metastatic Colorectal Cancer

The approval of targeted therapies for metastatic colorectal cancer (mCRC) has led to important improvements in patient outcomes. However, it is still necessary to increase individualisation of treatments based on tumour genetic profiles to optimise efficacy, while minimising toxicity. As such, ther...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Drugs
Main Authors: Taieb, Julien, Jung, Andreas, Sartore-Bianchi, Andrea, Peeters, Marc, Seligmann, Jenny, Zaanan, Aziz, Burdon, Peter, Montagut, Clara, Laurent-Puig, Pierre
Format: Artigo
Jezik:Inglês
Izdano: Springer International Publishing 2019
Teme:
Review Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6728290/
https://ncbi.nlm.nih.gov/pubmed/31347092
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-019-01165-2
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki